|Bid||14.64 x 1800|
|Ask||14.64 x 4000|
|Day's range||14.42 - 15.51|
|52-week range||4.41 - 67.00|
|Beta (5Y monthly)||2.62|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2021 - 13 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||18.82|
The cannabis business can be very boom-and-bust. It's important to realize what part of the cycle we're in now.
It's a fact of investing life that growth stocks are easier to find in growing industries than in mature or stagnating ones. With its 83 dispensaries in Florida and a small but growing number outside the state, Trulieve Cannabis (OTC: TCNNF) is one of the fastest-growing medicinal cannabis operators in the U.S. And Trulieve's growth is poised to accelerate thanks to its investment in new hubs outside the Sunshine State. By the end of this year, the company could be making as much as $850 million in revenue.
Tilray (NASDAQ: TLRY), the big marijuana operator resulting from the recent merger of the namesake company with the former Aprhia, is a stock on fire this week. The "new" Tilray reported its fourth-quarter fiscal 2021 figures on Wednesday, and they looked awfully sweet. Net revenue rose a sturdy 25% year over year to $142 million (taking into account Aphria's performance as a separate company in the year-ago period).